0

Journal Articles

in Health Policy/Health Economics
 101-120 of 890 Articles
Capitol Health Call |  October 10, 2012
Reducing Residency Shortage
Mike Mitka, MSJ
JAMA. 2012;308(14):1421. doi:10.1001/jama.2012.13454.
Original Contribution |  October 10, 2012 FREE
Association of Public Reporting for Percutaneous Coronary Intervention With Utilization and Outcomes Among Medicare Beneficiaries With Acute Myocardial Infarction
Karen E. Joynt, MD, MPH; Daniel M. Blumenthal, MD, MBA; E. John Orav, PhD; et al.
JAMA. 2012;308(14):1460-1468. doi:10.1001/jama.2012.12922.
INCLUDES: , Supplemental Content
Viewpoint |  October 10, 2012
Innovations in Care Delivery to Slow Growth of US Health Spending
Arnold Milstein, MD, MPH; Stephen Shortell, PhD, MBA, MPH
JAMA. 2012;308(14):1439-1440. doi:10.1001/jama.2012.12659.
Viewpoint |  October 10, 2012
The FDA Safety and Innovation Act
Robert Steinbrook, MD; Joshua M. Sharfstein, MD
JAMA. 2012;308(14):1437-1438. doi:10.1001/jama.2012.12829.
Viewpoint |  October 03, 2012
A New Model for Medical Education:  Celebrating Restraint
Allan S. Detsky, MD, PhD; Amol A. Verma, MD, MPhil
JAMA. 2012;308(13):1329-1330. doi:10.1001/2012.jama.11869.
Editorial |  September 26, 2012
Increasing Use of Total Knee Replacement and Revision Surgery
James Slover, MD, MS; Joseph D. Zuckerman, MD
JAMA. 2012;308(12):1266-1268. doi:10.1001/jama.2012.12644.
Health Agencies Update |  September 26, 2012
Sick Leave Benefits
Bridget M. Kuehn
JAMA. 2012;308(12):1198. doi:10.1001/2012.jama.12016.
Original Contribution |  September 26, 2012 FREE
Total Knee Arthroplasty Volume, Utilization, and Outcomes Among Medicare Beneficiaries, 1991-2010
Peter Cram, MD, MBA; Xin Lu, MS; Stephen L. Kates, MD; et al.
JAMA. 2012;308(12):1227-1236. doi:10.1001/2012.jama.11153.
INCLUDES: , Supplemental Content
Visualizing Health Policy |  September 26, 2012 FREE
Costs
Kaiser Family Foundation*
JAMA. 2012;308(12):1197. doi:10.1001/2012.jama.11916.
Viewpoint |  September 26, 2012
Overcoming the Pricing Power of Hospitals
Bob Kocher, MD; Ezekiel J. Emanuel, MD, PhD
JAMA. 2012;308(12):1213-1214. doi:10.1001/2012.jama.11910.
Viewpoint |  September 26, 2012
Bringing Diagnosis Into the Quality and Safety Equations
Mark L. Graber, MD; Robert M. Wachter, MD; Christine K. Cassel, MD, MSc
JAMA. 2012;308(12):1211-1212. doi:10.1001/2012.jama.11913.
From the Centers for Disease Control and Prevention |  September 26, 2012 FREE
Helmet Use Among Motorcyclists Who Died in Crashes and Economic Cost Savings Associated With State Motorcycle Helmet Laws—United States, 2008–2010
JAMA. 2012;308(12):1201-1203. doi:.
Viewpoint |  September 26, 2012 FREE
Controlling Health Care Costs in Massachusetts With a Global Spending Target
Robert Steinbrook, MD
JAMA. 2012;308(12):1215-1216. doi:10.1001/2012.jama.11322.
Original Contribution |  September 19, 2012 FREE
Health Care Use During 20 Years Following Bariatric Surgery
Martin Neovius, PhD; Kristina Narbro, PhD; Catherine Keating, MPH; et al.
JAMA. 2012;308(11):1132-1141. doi:10.1001/2012.jama.11792.
INCLUDES: , Supplemental Content
Viewpoint |  September 19, 2012
The Role of Government in Preventing Excess Calorie Consumption:  The Example of New York City
Thomas A. Farley, MD, MPH
JAMA. 2012;308(11):1093-1094. doi:10.1001/2012.jama.11623.
Medical News and Perspectives |  September 12, 2012
Lessons From Massachusetts: Cost Remains a Hurdle for Those With Public Insurance
Bridget M. Kuehn
JAMA. 2012;308(10):961-962. doi:10.1001/2012.jama.10939.
Original Contribution |  September 12, 2012 FREE
Spending Differences Associated With the Medicare Physician Group Practice Demonstration
Carrie H. Colla, PhD; David E. Wennberg, MD, MPH; Ellen Meara, PhD; et al.
JAMA. 2012;308(10):1015-1023. doi:10.1001/2012.jama.10812.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  September 05, 2012
Critics of US House Proposal to Ax AHRQ Say Idea Is Penny-wise and Pound-foolish
Mike Mitka
JAMA. 2012;308(9):849-850. doi:10.1001/2012.jama.10500.
Medical News and Perspectives |  September 05, 2012
European Drug Agency Works to Improve Transparency, but Skepticism Remains
Tracy Hampton, PhD
JAMA. 2012;308(9):850-851. doi:10.1001/2012.jama.10451.
Viewpoint |  September 05, 2012
The Safety Risks of Innovation:  The FDA's Expedited Drug Development Pathway
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA. 2012;308(9):869-870. doi:10.1001/jama.2012.9658.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 6, 2013
Coverage With Evidence Development for Medicare Beneficiaries:  Challenges and Next Steps
Gregory W. Daniel, PhD, MPH; Erin K. Rubens, MPH, MBA; Mark McClellan, MD, PhD
JAMA Internal Medicine
Invited Commentary  |  May 6, 2013
Supporting High-Value Part D Medicare Choices for Low-Income Beneficiaries:  Comment on “Cognition and Take-up of Subsidized Drug Benefits by Medicare Beneficiaries”
Karen L. Margolis, MD, MPH
JAMA Internal Medicine
Original Investigation  |  May 6, 2013
Cost Consideration in the Clinical Guidance Documents of Physician Specialty Societies in the United States
Jennifer A. T. Schwartz, MD; Steven D. Pearson, MD, MSc
JAMA Internal Medicine
Original Investigation  |  May 6, 2013
Cognition and Take-up of Subsidized Drug Benefits by Medicare Beneficiaries
Ifedayo O. Kuye, AB; Richard G. Frank, PhD; J. Michael McWilliams, MD, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems